Читать книгу Anti-Aging Therapeutics Volume XIII - A4M American Academy - Страница 6

A primary goal in prostate and other cancers is to identify aggressive cancers that can kill, as opposed to cancers that do not threaten life, and may not even show any symptoms. The current, widely-used diagnostic techniques make this identification extremely elusive. The technology to achieve this diagnostic distinction should be noninvasive, and provide measures that can be easily and accurately compared to previous exams, making it easy to track changes. At the same time, it should provide a systematic approach to monitoring the patient’s response to therapeutic intervention. In this way the diagnosis, monitoring and treatment can be tailored to each individual’s circumstances and responsiveness.

With recent advances in the technology of Doppler ultrasound and MRI, these goals can and are being achieved. Until recently this diagnostic technology has required extensive experience and training in interpreting the images. Now, advances in the computerization of the imaging, blood flow, and tumor measures of exact size and density, provide for an accurate and repeatable diagnosis, and a means to follow the individual’s unique pattern of cancer development, progress, and response to treatment. Recent technological advances also make these procedures available to much broader clinical application, without requiring years of very unique training and experience, and these advances are applicable beyond prostate cancer (PCa), the example used here.

In this paper, the noninvasive diagnostic tracking of a patient’s progress is presented, along with a naturopathic nutritional approach, the Beta-Sitosterol/Antioxidant Matrix (B-Sit/AOX), which provides vital support for cell function and membrane integrity. The B-Sit/AOX Matrix properly restores essential nutrition that has been systematically removed from our food supply. It systemically supports the body, and is especially targeted to naturally restore cell membrane elasticity and permeability, apoptosis, reduce cell proliferation, and reestablish a healthy intracellular environment that naturally protects against metastases. This directly nourishes the body’s natural cancer prevention mechanisms, and is appropriate for healthy individuals, for individuals during cancer episodes, and for post-episode maintenance. Following men with PCa using Doppler imaging has shown that an appropriate B-Sit/AOX formulation is effective and successful for a wide range of men with diagnosed PCa who elect proactive watchful waiting. The evaluation of nearly 10-years of patient records for men opting for proactive watchful waiting (Gleason scores ranging from 5 to 9) using the B-Sit/AOX Matrix has demonstrated the success of this nutritional approach – with the result being approximately 90% of men showed significant reduction or full stabilization of vascular indices for non-aggressive cancers, and the same improvement was shown in about 70% of men with aggressive cancers, over a 10-year period. Careful monitoring also provides the basis for deciding on other available treatment options, if necessary.

The success of coupling noninvasive monitoring with key nutrition provides a robust basis for tailoring intervention to an individual. This system provides a reliable evaluation of each person on a case-by-case criterion. Thus we are able to evaluate the individual’s ability to respond to nutritional and life-style intervention, and the potential need for more invasive medical intervention and treatment, while reducing unnecessary invasive treatments.